A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures
Author(s) -
Vincenzo A. Gennarino,
Elizabeth E. Palmer,
Laura M. McDonell,
Li Wang,
Carolyn J. Adamski,
Amanda Koire,
Lauren See,
ChunAn Chen,
Christian P. Schaaf,
Jill A. Rosenfeld,
Jessica A. Panzer,
Ute Moog,
Shuang Hao,
Ann Bye,
Edwin P. Kirk,
Paweł Stankiewicz,
Amy M. Breman,
Arran McBride,
Tejaswi Kandula,
Holly Dubbs,
Rebecca Macintosh,
Michael Cardamone,
Ying Zhu,
Kevin Ying,
KerithRae Dias,
Megan T. Cho,
Lindsay B. Henderson,
Berivan Baskin,
Paula Morris,
Tao Jiang,
Mark J. Cowley,
Marcel E. Dinger,
Tony Roscioli,
Oana Caluseriu,
Oksana Suchowersky,
Rani Sachdev,
Olivier Lichtarge,
Jianrong Tang,
Kym M. Boycott,
J. Lloyd Holder,
Huda Y. Zoghbi
Publication year - 2018
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2018.02.006
Subject(s) - haploinsufficiency , missense mutation , biology , ataxia , genetics , penetrance , neurodegeneration , mutation , phenotype , gene , medicine , disease , neuroscience
Certain mutations can cause proteins to accumulate in neurons, leading to neurodegeneration. We recently showed, however, that upregulation of a wild-type protein, Ataxin1, caused by haploinsufficiency of its repressor, the RNA-binding protein Pumilio1 (PUM1), also causes neurodegeneration in mice. We therefore searched for human patients with PUM1 mutations. We identified eleven individuals with either PUM1 deletions or de novo missense variants who suffer a developmental syndrome (Pumilio1-associated developmental disability, ataxia, and seizure; PADDAS). We also identified a milder missense mutation in a family with adult-onset ataxia with incomplete penetrance (Pumilio1-related cerebellar ataxia, PRCA). Studies in patient-derived cells revealed that the missense mutations reduced PUM1 protein levels by ∼25% in the adult-onset cases and by ∼50% in the infantile-onset cases; levels of known PUM1 targets increased accordingly. Changes in protein levels thus track with phenotypic severity, and identifying posttranscriptional modulators of protein expression should identify new candidate disease genes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom